InvivoGen's product citations
InvivoGen’s products are frequently cited in peer-reviewed publications for a wide variety of applications and uses. Browse our product citations below.
Please note: By clicking on the product name, you can access via the ‘Citations’ tab all references of the product (click ‘load more’).
Citations search
You can search by ‘Product Name’ or ‘Year’.
Product | Citation | Year | Journal | Authors | Page |
---|---|---|---|---|---|
3'3'-cGAMP | Macrophage phagocytosis of SARS-CoV-2-infected cells mediates potent plasmacy... | 2023 | Cell Mol Immunol. | García-Nicolás O. et al. | DOI: 10.1038/s41423-023-01039-4 |
Hygromycin B Gold | Macrophage phagocytosis of SARS-CoV-2-infected cells mediates potent plasmacy... | 2023 | Cell Mol Immunol. | García-Nicolás O. et al. | DOI: 10.1038/s41423-023-01039-4 |
Puromycin | Macrophage phagocytosis of SARS-CoV-2-infected cells mediates potent plasmacy... | 2023 | Cell Mol Immunol. | García-Nicolás O. et al. | DOI: 10.1038/s41423-023-01039-4 |
Human ACE2 & TMPRSS2 expressing A549 Cells | Macrophage phagocytosis of SARS-CoV-2-infected cells mediates potent plasmacy... | 2023 | Cell Mol Immunol. | García-Nicolás O. et al. | DOI: 10.1038/s41423-023-01039-4 |
ODN 2006 (ODN 7909) | Macrophage phagocytosis of SARS-CoV-2-infected cells mediates potent plasmacy... | 2023 | Cell Mol Immunol. | García-Nicolás O. et al. | DOI: 10.1038/s41423-023-01039-4 |
Ruxolitinib | Macrophage phagocytosis of SARS-CoV-2-infected cells mediates potent plasmacy... | 2023 | Cell Mol Immunol. | García-Nicolás O. et al. | DOI: 10.1038/s41423-023-01039-4 |
Puromycin | Kinetics of RTK activation determine ERK reactivation and resistance to dual ... | 2023 | Cell Rep. | Kim S. et al. | DOI: 10.1016/j.celrep.2023.112570 |
Blasticidin | Kinetics of RTK activation determine ERK reactivation and resistance to dual ... | 2023 | Cell Rep. | Kim S. et al. | DOI: 10.1016/j.celrep.2023.112570 |
R848 VacciGrade™ | Peyer's patch phagocytes acquire specific transcriptional programs that influ... | 2023 | Mucosal Immunol. | Arroyo Portilla C. et al. | DOI: 10.1016/j.mucimm.2023.05.009 |
R848 (Resiquimod) | Clinical characteristics and host immunity responses of SARS-CoV-2 Omicron va... | 2023 | Virol J. | Tang Z. et al. | DOI: 10.1186/s12985-023-02066-3 |
Plasmocin® - Mycoplasma Elimination Reagent | Cell consequences of loss of function of the epigenetic factor EHMT1. | 2023 | Cell Signal | Iglesias-Ortega L. et al. | DOI: 10.1016/j.cellsig.2023.110734 |
Blasticidin | Efficient generation of TBX3+ atrioventricular conduction-like cardiomyocytes... | 2023 | BBRC | Du R. et al. | DOI: 10.1016/j.bbrc.2023.05.104 |
Normocin® - Antimicrobial Reagent | Protocol for measuring transcytosis and recycling of IgG in intestinal epithe... | 2023 | STAR Protoc. | Maeda K. et al. | DOI: 10.1016/j.xpro.2023.102335 |
Primocin® | Protocol for measuring transcytosis and recycling of IgG in intestinal epithe... | 2023 | STAR Protoc. | Maeda K. et al. | DOI: 10.1016/j.xpro.2023.102335 |
ODN TTAGGG (A151) | Tricyclic antidepressants induce liver inflammation by targeting NLRP3 inflam... | 2023 | Cell Commun Signal. | Mu W. et al. | DOI: 10.1186/s12964-023-01128-x |
Hygromycin B Gold | The deubiquitinase OTUB1 governs lung cancer cell fitness by modulating prote... | 2023 | Biochim Biophys Acta Mol Basis Dis. | Sheryazdanova A. et al. | DOI: 10.1016/j.bbadis.2023.166767 |
Puromycin | The deubiquitinase OTUB1 governs lung cancer cell fitness by modulating prote... | 2023 | Biochim Biophys Acta Mol Basis Dis. | Sheryazdanova A. et al. | DOI: 10.1016/j.bbadis.2023.166767 |
Human TLR4 Reporter HEK293 Cells (NF-κB) | Bioaerosol-induced in vitro activation of toll-like receptors and inflammator... | 2023 | Int Arch Occup Environ Health | Eriksen E. et al. | DOI: 10.1007/s00420-023-01984-7 |
QUANTI-Blue™ | Bioaerosol-induced in vitro activation of toll-like receptors and inflammator... | 2023 | Int Arch Occup Environ Health | Eriksen E. et al. | DOI: 10.1007/s00420-023-01984-7 |
Human TLR2 Reporter HEK293 Cells (NF-κB) | Bioaerosol-induced in vitro activation of toll-like receptors and inflammator... | 2023 | Int Arch Occup Environ Health | Eriksen E. et al. | DOI: 10.1007/s00420-023-01984-7 |